Cargando…
SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end‐joining
BACKGROUND: DNA double‐strand breaks (DSBs) are harmful to the cell as it could lead to genomic instability and cell death when left unrepaired. Homologous recombination and nonhomologous end‐joining (NHEJ) are two major DSB repair pathways, responsible for ensuring genome integrity in mammals. Ther...
Autores principales: | Manjunath, Meghana, Choudhary, Bibha, Raghavan, Sathees C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222562/ https://www.ncbi.nlm.nih.gov/pubmed/33496064 http://dx.doi.org/10.1002/cnr2.1341 |
Ejemplares similares
-
Nonhomologous DNA End Joining in Cell-Free Extracts
por: Sharma, Sheetal, et al.
Publicado: (2010) -
Microhomology-mediated end joining is the principal mediator of double-strand break repair during mitochondrial DNA lesions
por: Tadi, Satish Kumar, et al.
Publicado: (2016) -
The Minimal Bacillus subtilis Nonhomologous End Joining Repair Machinery
por: de Vega, Miguel
Publicado: (2013) -
Evolutionary and Comparative Analysis of Bacterial Nonhomologous End Joining Repair
por: Sharda, Mohak, et al.
Publicado: (2020) -
Resolution of complex ends by Nonhomologous end joining - better to be lucky than good?
por: Strande, Natasha Tiffany, et al.
Publicado: (2012)